Gregory Reyes

Dr. Reyes has over 30 years of biotech/large pharma leadership experience spanning multiple therapeutic areas. His teams have nominated and progressed over 50 compounds, both small molecules and biologics, from discovery into preclinical and clinical development. Dr. Reyes’ most recent role was as Senior Vice President in charge of their global Drug Discovery efforts at Celgene Corporation. Under Dr. Reyes’ leadership at Schering-Plough (now Merck), Victrelis™ (boceprevir) was discovered and later gained approval for the treatment of chronic hepatitis C. This seminal work in the discovery and development of the first hepatitis C virus protease inhibitor led to the 2012 Prix Galien Award shared by Victrelis™ and Vertex’s Incivek™ as the ‘best pharmaceutical agent’ in both the UK and US. In addition to the companies mentioned above, Dr. Reyes also held a VP position at Pfizer.